Metabolomic Diagnostics, is pleased to announce that it has secured €750,000 ($1.03m) in venture funding through a syndicate of investors including SOS ventures Ireland Fund, AIB Seed Capital Fund and Enterprise Ireland.
“We are delighted to be backing Metabolomic diagnostics as they have a great team and a real shot at significant and speedy commercial success. Their product has a real chance of saving the lives of mothers and their babies which is pretty cool.” said Bill Liao, european venture partner, SOSventures International. The Irish Minister for Research and Innovation, Sean Sherlock TD, welcomed the investment stating “This is an important investment, given the potential significance of this metabolomic diagnostic test, the results of which include saving lives. I look forward to following the results of this innovative technology in the future.”
The company has been privately funded to date, following the licensing of its technology from University College Cork. This Series A round is the first external funding which the company has taken and will allow it to continue its work to validate and refine its PrePsia early pregnancy screening test for pre-eclampsia.